Total Payments
$7,396
2024 Payments
$3,370
Companies
21
Transactions
257
Medicare Patients
1,374
Medicare Billing
$102,565
Payment Breakdown by Category
Food & Beverage$7,209 (97.5%)
Education$186.98 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,209 | 255 | 97.5% |
| Education | $186.98 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $1,561 | 48 | $0 (2024) |
| Dermavant Sciences, Inc. | $1,501 | 33 | $0 (2024) |
| ABBVIE INC. | $680.64 | 39 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $586.55 | 15 | $0 (2024) |
| Amgen Inc. | $520.80 | 22 | $0 (2024) |
| Incyte Corporation | $411.95 | 15 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $398.63 | 20 | $0 (2024) |
| PFIZER INC. | $287.49 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $278.14 | 14 | $0 (2024) |
| DePuy Synthes Sales Inc. | $252.81 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,370 | 104 | Dermavant Sciences, Inc. ($1,022) |
| 2023 | $2,343 | 89 | Dermavant Sciences, Inc. ($479.04) |
| 2022 | $887.72 | 43 | GENZYME CORPORATION ($413.99) |
| 2021 | $795.33 | 21 | GENZYME CORPORATION ($179.13) |
All Payment Transactions
257 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $33.13 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.15 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.95 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: Dermatology | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $0.35 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.93 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Dermatology | ||||||
| 09/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.44 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 401 | 786 | $99,959 | $28,065 |
| 2022 | 10 | 361 | 685 | $58,837 | $26,582 |
| 2021 | 9 | 341 | 783 | $61,143 | $28,191 |
| 2020 | 7 | 271 | 521 | $42,266 | $19,727 |
Total Patients
1,374
Total Services
2,775
Medicare Billing
$102,565
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 111 | $28,553 | $7,904 | 27.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 51 | 61 | $13,664 | $4,251 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $11,604 | $3,383 | 29.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 27 | 32 | $10,981 | $3,074 | 28.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 36 | 39 | $7,877 | $2,055 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 40 | $6,990 | $1,947 | 27.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 52 | 63 | $8,551 | $1,692 | 19.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 48 | 360 | $4,854 | $1,612 | 33.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $4,909 | $1,423 | 29.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 20 | $1,975 | $723.15 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 83 | $12,711 | $6,177 | 48.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 52 | 70 | $10,134 | $4,810 | 47.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 68 | $7,955 | $3,291 | 41.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 28 | 31 | $6,534 | $3,272 | 50.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $5,975 | $2,947 | 49.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 34 | 35 | $4,385 | $1,718 | 39.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 40 | 49 | $4,221 | $1,374 | 32.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 36 | 280 | $2,498 | $1,277 | 51.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $3,472 | $1,195 | 34.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 12 | 14 | $952.40 | $522.59 | 54.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 106 | $12,168 | $5,745 | 47.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 46 | 78 | $11,283 | $5,637 | 50.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 60 | $9,858 | $4,719 | 47.9% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 18 | 28 | $5,792 | $3,081 | 53.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 34 | 40 | $5,141 | $2,010 | 39.1% |
About Ray Lin
Ray Lin is a Medical healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2014. The National Provider Identifier (NPI) number assigned to this provider is 1649693540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ray Lin has received a total of $7,396 in payments from pharmaceutical and medical device companies, with $3,370 received in 2024. These payments were reported across 257 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($7,209).
As a Medicare-enrolled provider, Lin has provided services to 1,374 Medicare beneficiaries, totaling 2,775 services with total Medicare billing of $102,565. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Other Specialties Medical
- Location Riverside, CA
- Active Since 01/28/2014
- Last Updated 07/21/2016
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1649693540
Products in Payments
- VTAMA (Drug) $1,501
- DUPIXENT (Biological) $1,133
- Otezla (Drug) $520.80
- SKYRIZI (Biological) $458.05
- COSENTYX (Drug) $346.93
- OPZELURA (Drug) $316.96
- TREMFYA (Drug) $256.16
- NA (Device) $252.81
- ADBRY (Biological) $248.77
- RINVOQ (Biological) $189.04
- Sotyktu (Drug) $154.22
- CIBINQO (Drug) $146.15
- EUCRISA (Drug) $141.34
- Winlevi (Drug) $96.93
- COSENTYX (Biological) $51.70
- TALTZ (Drug) $50.60
- HUMIRA (Biological) $33.55
- LIBTAYO (Biological) $26.53
- REMICADE (Biological) $21.98
- Zoryve (Drug) $21.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Riverside
Hector Veron, Pa, PA
Medical — Payments: $5,912
Medical $5,912
Ms. Jean Huynh, Pa-C, PA-C
Medical — Payments: $4,191
Medical $4,191
Mrs. Liana Marino, Pa-C, PA-C
Medical — Payments: $3,624
Medical $3,624
Mrs. Annamae Minard, Pa-C, PA-C
Medical — Payments: $3,578
Medical $3,578
Belen Sachs, Pa-C, PA-C
Medical — Payments: $3,128
Medical $3,128
Grace Mcdonald
Medical — Payments: $2,334
Medical $2,334